Hospital at home for oncologic patients: SEOM-SEHAD consensus on clinical practice.

IF 2.5 3区 医学 Q2 ONCOLOGY
Clinical & Translational Oncology Pub Date : 2025-10-01 Epub Date: 2025-04-23 DOI:10.1007/s12094-025-03875-4
Eulalia B Villegas Bruguera, Kevin Molina Mata, Magdalena Fernandez Martinez de Mandojana, Iosune Guillén Blanco, Manuel Sánchez Cánovas
{"title":"Hospital at home for oncologic patients: SEOM-SEHAD consensus on clinical practice.","authors":"Eulalia B Villegas Bruguera, Kevin Molina Mata, Magdalena Fernandez Martinez de Mandojana, Iosune Guillén Blanco, Manuel Sánchez Cánovas","doi":"10.1007/s12094-025-03875-4","DOIUrl":null,"url":null,"abstract":"<p><p>The number of oncologic patients and survival rates are increasing worldwide. This fact implies greater comorbidity and complications associated with cancer and oncologic therapies. Many of these complications require hospitalization which constitutes an additional risk factor for the patient, due to the nosocomial burden such as infections, severe functional deficits or depression. Moreover, the increasing number of hospitalizations implies a significant increase in global sanitary costs. Hospital at Home (HaH) is a resource that allows decompensated patient to remain in home, attended and treated by a hospital multidisciplinary team. Furthermore, HaH has been shown to be clearly cost-effective in multiple pathologies compared to conventional hospitalization. A group of experts from the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Hospital at Home (SEHAD) met to discuss a brief update on home complex attention of oncologic patients and agree on aspects relating to the clinical diagnosis, admission criteria and management of different profiles.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":"3860-3866"},"PeriodicalIF":2.5000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460374/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-025-03875-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The number of oncologic patients and survival rates are increasing worldwide. This fact implies greater comorbidity and complications associated with cancer and oncologic therapies. Many of these complications require hospitalization which constitutes an additional risk factor for the patient, due to the nosocomial burden such as infections, severe functional deficits or depression. Moreover, the increasing number of hospitalizations implies a significant increase in global sanitary costs. Hospital at Home (HaH) is a resource that allows decompensated patient to remain in home, attended and treated by a hospital multidisciplinary team. Furthermore, HaH has been shown to be clearly cost-effective in multiple pathologies compared to conventional hospitalization. A group of experts from the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Hospital at Home (SEHAD) met to discuss a brief update on home complex attention of oncologic patients and agree on aspects relating to the clinical diagnosis, admission criteria and management of different profiles.

肿瘤患者的家庭医院:SEOM-SEHAD对临床实践的共识。
在世界范围内,肿瘤患者的数量和生存率都在增加。这一事实意味着与癌症和肿瘤治疗相关的更多的合并症和并发症。其中许多并发症需要住院治疗,由于感染、严重功能缺陷或抑郁等医院负担,这对患者构成了额外的风险因素。此外,住院人数的增加意味着全球卫生费用的大幅增加。家庭医院(HaH)是一种资源,允许失代偿患者留在家中,由医院多学科团队护理和治疗。此外,与传统住院相比,HaH已被证明在多种疾病中具有明显的成本效益。来自西班牙肿瘤医学学会(SEOM)和西班牙家庭医院学会(SEHAD)的一组专家开会讨论了肿瘤患者家庭复杂护理的简要更新,并就临床诊断、入院标准和不同概况的管理等方面达成一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
2.90%
发文量
240
审稿时长
1 months
期刊介绍: Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信